Purpose
|
Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994.
|
Characteristics
|
Tradename: MODRASTANE Source of Compound: semisynthetic, WIN-24540 Target: Estrogen receptor allosteric modulator Receptor: HSD3B,Estrogen receptor Status: USAN, INN, BAN, JAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C20H27NO3
|
Solubility
|
DMSO 65 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |